Article info
Original research
Surgical ovarian suppression for adjuvant treatment in hormone receptor positive breast cancer in premenopausal patients
- Correspondence to Dr Oliver Zivanovic, Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; zivanovo{at}mskcc.org
Citation
Surgical ovarian suppression for adjuvant treatment in hormone receptor positive breast cancer in premenopausal patients
Publication history
- Received August 21, 2020
- Revision received October 22, 2020
- Accepted October 27, 2020
- First published December 3, 2020.
Online issue publication
February 01, 2021
Article Versions
- Previous version (3 December 2020).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.